US Stocks
/
Silexion Therapeutics Corp Warrant Share Price

Silexion Therapeutics Corp Warrant Share Price

NASDAQ: SLXNW | Micro Cap
$0.05
+$0.05 (--%) Last updated on 23 Jul, 2026 | 22:21 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Silexion Therapeutics Corp Warrant Stock Performance

Open
$0.04
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.04 - $0.07
Year Range
$0.03 - $0.07
Volume
6,300
Average Traded
$0.05

Silexion Therapeutics Corp Warrant Share Price Chart

$0.04$0.07
L
Show Current Price
H

Silexion Therapeutics Corp Warrant Stock Fundamentals & Key Indicators

Market Cap
$62221.30
PE Ratio (TTM)
0.01
Dividend Yield
N/A
EPS (TTM)
$8.96
Revenue (TTM)
N/A
Return On Equity (TTM)
-457.63%
Profit Margin
N/A
Debt to Equity
1.06
Quarterly Earnings Growth YoY
72.50%

Silexion Therapeutics Corp Warrant Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/A
Net Profit-$1.49M-$11.86M-$1.74M-$2.50M-$3.26M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-696.51%85.37%-44.27%-30.32%

Silexion Therapeutics Corp Warrant Annual Profit & Loss

All figures in USD

Particulars20242025
RevenueN/AN/A
Net Profit-$16.52M-$11.91M
Net Profit MarginN/AN/A
Income ChangeN/A27.89%

About Silexion Therapeutics Corp Warrant

Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform. Its products comprise SiG12D-LODER that has completed pre-clinical studies and an open label Phase I clinical trial for the treatment of pancreatic cancer; Prostate-LODER, which is in pre-clinical studies for the treatment of prostate cancer; and GBM-LODER that is in pre-clinical studies to target Glioblastoma Multiform, a malignant primary brain tumor. Silexion Therapeutics Corp has collaboration with Evonik Corporation for the development of an advanced siRNA formulation to enhance cancer treatment. The company was founded in 2008 and is headquartered in Jerusalem, Israel.

Silexion Therapeutics Corp Warrant Historical Returns

MonthOpenCloseChange %
Jul 2026
$0.04
$0.05
+4.55%
Jun 2026
$0.05
$0.04
-38.03%
Dec 2025
$0.07
$0.07
+136.67%
Aug 2025
$0.04
$0.03
-28.57%
Jul 2025
$0.04
$0.04
+5.00%
Jun 2025
$0.05
$0.04
-18.37%
May 2025
$0.06
$0.05
-12.50%
Apr 2025
$0.08
$0.06
-26.32%
Mar 2025
$0.07
$0.08
+26.67%
Feb 2025
$0.08
$0.06
-27.71%
Jan 2025
$0.03
$0.08
+151.52%
Dec 2024
$0.02
$0.03
+13.79%

SLXNW Share Price FAQs

What is Silexion Therapeutics Corp Warrant share price today?

chevron-up
Silexion Therapeutics Corp Warrant share price today is $0.05 as on July 23, 2026 at 10:21 pm IST.

What is the 52 week high and 52 week low of Silexion Therapeutics Corp Warrant stock?

chevron-up
The 52 week high of Silexion Therapeutics Corp Warrant stock is $0.07, while the 52 week low is $0.03 as of 23 Jul '26.

What is SLXNW's market capitalisation today?

chevron-up
SLXNW market capitalisation is $62221.30 as of August 10, 2026, at 4:19 pm IST.

What is SLXNW's net income for the last quarter?

chevron-up
SLXNW's net income for the last quarter is -0.00B USD.

What is the 5 year returns of SLXNW?

chevron-up
The 5 year returns of SLXNW is -91.69% as on 23 Jul '26.

What is the high & low stock price of SLXNW today?

chevron-up
SLXNW stock price hit a high of $0.07 and low of $0.04 as of 23 Jul '26.

Can I buy SLXNW shares in India?

chevron-up
Yes. You can buy SLXNW in India by opening an international trading account.